Caitong International Asset Management Co., LTD Aldeyra Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 171 shares of ALDX stock, worth $355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171Holding current value
$355% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALDX
# of Institutions
139Shares Held
38.5MCall Options Held
620KPut Options Held
435K-
Perceptive Advisors LLC New York, NY9.28MShares$19.3 Million2.23% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$11.4 Million21.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.72MShares$7.73 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$7.53 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.75MShares$3.64 Million2.26% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $121M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...